Both donor and recipient CYP3A5 gene polymorphisms represent as significant factors influencing Tacrolimus weight-dose adjusted concentration in the early phase after living donor liver transplantation

Pharmaceutical Sciences Asia · Published 2024-12-25 · DOI 10.29090/psa.2025.01.24.ab0741

Authors being retrieved — see the publisher record. https://doi.org/10.29090/psa.2025.01.24.ab0741

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2024

Related articles